ALB was experimentally shown to be a tumor suppressor in hepatocellular carcinomas (Nojiri & Joh, 2014), and has been discussed as an important part of the somatic mutation landscape (Cancer Genome Atlas Network, 2017). This evidence concerns the gene ALB and neoplasm.